Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries.
- DOI
- 10.2165/00019053-199406060-00008
- Published
- 1994 Dec
- Container
- PharmacoEconomics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2165/00019053-199406060-00008,
title = {Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries.},
author = {Simpson K and Hatziandreu EJ and Andersson F and Shakespeare A and Oleksy I and Tosteson AN},
year = {1994},
journal = {PharmacoEconomics},
doi = {10.2165/00019053-199406060-00008},
url = {https://doi.org/10.2165/00019053-199406060-00008}
}RIS
TY - JOUR TI - Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries. AU - Simpson K AU - Hatziandreu EJ AU - Andersson F AU - Shakespeare A AU - Oleksy I AU - Tosteson AN PY - 1994 JO - PharmacoEconomics DO - 10.2165/00019053-199406060-00008 UR - https://doi.org/10.2165/00019053-199406060-00008 ER -
APA
K, S., EJ, H., F, A., A, S., I, O., & AN, T. (1994). Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries.. PharmacoEconomics. https://doi.org/10.2165/00019053-199406060-00008
Source records
- pubmed · retrieved 2026-09-27T07:35:19.875Z